| Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents LR Chiarelli, M Mori, D Barlocco, G Beretta, A Gelain, E Pini, M Porcino, ... European journal of medicinal chemistry 155, 754-763, 2018 | 68 | 2018 |
| New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular … E Pini, G Poli, T Tuccinardi, LR Chiarelli, M Mori, A Gelain, L Costantino, ... Molecules 23 (7), 1506, 2018 | 38 | 2018 |
| New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents LR Chiarelli, M Mori, G Beretta, A Gelain, E Pini, JC Sammartino, ... Journal of Enzyme Inhibition and Medicinal Chemistry 34 (1), 823-828, 2019 | 33 | 2019 |
| Signal transducer and activator of transcription protein 3 (STAT3): an update on its direct inhibitors as promising anticancer agents A Gelain, M Mori, F Meneghetti, S Villa Current Medicinal Chemistry 26 (27), 5165-5206, 2019 | 31 | 2019 |
| An overview on the potential antimycobacterial agents targeting serine/threonine protein kinases from Mycobacterium tuberculosis M Mori, JC Sammartino, L Costantino, A Gelain, F Meneghetti, S Villa, ... Current Topics in Medicinal Chemistry 19 (9), 646-661, 2019 | 28 | 2019 |
| Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design M Mori, G Stelitano, A Gelain, E Pini, LR Chiarelli, JC Sammartino, G Poli, ... Journal of Medicinal Chemistry 63 (13), 7066-7080, 2020 | 26 | 2020 |
| Application of chiral bi-and tetra-dentate bispidine-derived ligands in the copper (ii)-catalyzed asymmetric Henry reaction A Rossetti, S Landoni, F Meneghetti, C Castellano, M Mori, GC Dugoni, ... New Journal of Chemistry 42 (14), 12072-12081, 2018 | 22 | 2018 |
| Discovery of novel naphthylphenylketone and naphthylphenylamine derivatives as cell division cycle 25B (CDC25B) phosphatase inhibitors: design, synthesis, inhibition mechanism … C Cerchia, R Nasso, M Mori, S Villa, A Gelain, A Capasso, F Aliotta, ... Journal of Medicinal Chemistry 62 (15), 7089-7110, 2019 | 19 | 2019 |
| Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation E Truzzi, F Meneghetti, M Mori, L Costantino, V Iannuccelli, E Maretti, ... Journal of colloid and interface science 541, 399-406, 2019 | 19 | 2019 |
| Crystallographic and NMR Investigation of Ergometrine and Methylergometrine, Two Alkaloids from Claviceps Purpurea F Meneghetti, P Ferraboschi, P Grisenti, S Reza Elahi, M Mori, S Ciceri Molecules 25 (2), 331, 2020 | 7 | 2020 |
| Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity L Legnani, D Colombo, A Venuti, C Pastori, L Lopalco, L Toma, M Mori, ... MedChemComm 8 (2), 422-433, 2017 | 7 | 2017 |
| Exploring the biological activity of a library of 1, 2, 5-oxadiazole derivatives endowed with antiproliferative activity A Gelain, M Mori, F Meneghetti, F Porta, L Basile, G Marverti, A Asai, ... Anticancer Research 39 (1), 135-144, 2019 | 5 | 2019 |
| Unravelling the Antiproliferative Activity of 1, 2, 5-oxadiazole Derivatives D Ehrsam, F Porta, M Mori, HEM Zu Schwabedissen, L Dalla Via, ... Anticancer research 39 (7), 3453-3461, 2019 | | 2019 |
| New synergic treatments for inhaled anti-TB therapy: a preliminary SANS study M Mori, S Villa, A Gelain, G Beretta, LR Chiarelli, L Costantino, ... | | 2017 |
| Design and synthesis of novel antituberculars targeting the salicylate synthase (MbtI) S Villa, LR Chiarelli, M Mori, A Gelain, L Costantino, D Bonanni, ... | | 2017 |
| Synthesis of novel furan-based antitubercolars potentially targeting the methionine aminopeptidases (MtMetAP1a) A Gelain, S Villa, M Mori, LR Chiarelli, L Costantino, T Tuccinardi, ... MEDICINAL CHEMISTRY 7 (4), 74-74, 2017 | | 2017 |
| SANS study of lipid-based nanocarriers as inhaled drug delivery systems for anti-tuberculosis chemotherapy F Meneghetti, C Castellano, M Mori, E Leo, V Iannuccelli, L Costantino, ... | | 2017 |
| Design and synthesis of novel furan-based MbtI inhibitors as potential antitubercular agents M Mori, S Villa, LR Chiarelli, A Gelain, L Costantino, T Tuccinardi, ... Proceedings of the Merck Young Chemists Symposium, 2017 | | 2017 |
